Managed Account Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Managed Account Advisors’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$5.62M	Buy	107,889 +5,858	+6%	+$291K	﹤0.01%	1367
2015 Q1	$4.75M	Buy	102,031 +6,537	+7%	+$339K	﹤0.01%	1449
2014 Q4	$4.29M	Buy	95,494 +1,054	+1%	+$44.3K	﹤0.01%	1472
2014 Q3	$3.68M	Buy	94,440 +23,702	+34%	+$930K	﹤0.01%	1515
2014 Q2	$2.99M	Sell	70,738 -2,797	-4%	-$103K	﹤0.01%	1610
2014 Q1	$2.62M	Buy	+73,535	New	+$2.48M	﹤0.01%	1633

Other funds holding ISEE

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

JCG

JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Managed Account Advisors's ISEE Position: Q2 2015 in Review

Managed Account Advisors increased its IVERIC bio, Inc. Common Stock (ISEE) stake by 5.7% in Q2 2015, buying an estimated $291K and bringing the position to 107,889 shares worth $5.62M. The position accounts for ﹤0.01% of the portfolio, ranked #1367.

Managed Account Advisors first reported a position in ISEE in Q1 2014 and has held it in 6 quarters since. 139 funds tracked by Wall St. Rank hold ISEE as of Q2 2015.

Managed Account Advisors held 107,889 shares of IVERIC bio, Inc. Common Stock worth $5.62M as of Q2 2015.
Managed Account Advisors bought 5,858 IVERIC bio, Inc. Common Stock shares in Q2 2015, an estimated $291K.
IVERIC bio, Inc. Common Stock made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1367 holding.
Managed Account Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q1 2014 and has held it in 6 quarters since.
139 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.